Dishman Pharmaceuticals and Chemicals Ltd <DISH.BO> said on Friday its Naroda plant near Ahmedabad has received US FDA approval for producing active pharmaceutical ingredients (API) meant for the ...

Sources said that contract research and manufacturing player Dishman Pharmaceuticals & Chemicals Ltd is close to clinch one more acquisition deal in Switzerland. AHMEDABAD: Gujarat CM Narendra ...

AHMEDABAD: Following a search-and-survey operation on Dishman Carbogen Amcis Ltd earlier this month, the state income tax (I-T) department has claimed to have found a trail of unaccounted for cash ...

Dishman Get EIR: Drug firm Dishman Pharmaceuticals and Chemicals Ltd has received Establishment Inspection Report (EIR) from the US health regulator on closure of inspection of its Bavla facility ...

Dishman Pharmaceuticals and Chemicals Limited has received SEBI acknowledgement for its proposed IPO of 3,433,400 equity shares of Rs.10 each.

Ahmedabad-based Dishman Pharmaceuticals and Chemicals Ltd today said it will acquire the pharmaceutical services business of US-based Solutia Inc for 74.5 million dollars.

India's Dishman Pharmaceuticals & Chemicals Ltd. said May 24 that it will buy Solutia Inc.'s pharmaceutical services business for $74.5 million.

Ahmedabad-based Dishman plans to invest 6.5 billion rupees over 3-5 years to set up two SEZs in Gujarat, one for pharma and the other for engineering.

Fire At Dishman Pharma: Drug firm Dishman Pharmaceuticals and Chemicals Ltd today said there was fire at one of the units of its Bavla facility on Tuesday evening.

Early stage drug development company Redx Pharma has announced a licence agreement that will allow Dishman Pharmaceuticals & Chemicals to use process technology patented by the Liverpool-based ...

The stock of contract research and manufacturing services (CRAMS) player, Dishman Pharma, is among those that have managed to beat the benchmark convincingly.

Dishman Pharmaceuticals and Chemicals Ltd said on Thursday said it has increased its stake in a local joint venture with a German partner to 72.33 per cent from 22.33 per cent for €300,000 (about $341 ...